Table 1.
Costs (US$) of one course of selected antidotes and annual Health expenditure per capita in selected Asia-Pacific countries.60
| Cost/treatment (US$) | Antidote * | Asia-Pacific Countries with annual per capita health expenditure in this range. |
|---|---|---|
| >$10 | Sodium Bicarbonate | Afghanistan, Laos |
| $10-20 | Activated charcoal in suspension. | Bangladesh, Indonesia, |
| Naloxone | Nepal, Pakistan | |
| $20-50 | Atropine (low dose) | Cambodia, China, India,Papua New Guinea,Mongolia, Philippines, SriLanka, Vietnam |
| $50-200 | Atropine (high dose) | Fiji, Malaysia, Maldives, |
| Pyridoxine | Myanmar, Samoa, Thailand, | |
| Succimer | Tonga | |
| Cyclophosphamide/Methyprednisolone | ||
| Flumazenil | ||
| Acetylcysteine | ||
| $200-1000 | Pralidoxime (low dose) | Singapore, South Korea |
| Desferroxamine | ||
| Hydroxocobalamin | ||
| >$1000 | Digoxin binding Fab antibodies, | Australia, New Zealand, |
| Pralidoxime (high dose) | Japan |
*
based on dose required in one severe adult poisoning - Australian Wholesale prices-December 2004